 |
|
|
Cuadro 1. Regímenes estándares de quimioterapia para el tumor de Wilms
|
Nombre del régimen
|
Descripción del régimen
|
| Régimen EE-4A [1] |
Vincristina, dactinomicina x 18 semanas posnefrectomía |
| Régimen DD-4A [1] |
Vincristina, dactinomicina, doxorrubicina x 24 semanas posnefrectomía |
| Régimen I [2] |
Vincristina, doxorrubicina, ciclofosfamida, etopósido x 24 semanas |
Bibliografía
-
Green DM, Breslow NE, Beckwith JB, et al.: Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 16 (1): 237-45, 1998.
[PUBMED Abstract]
-
Dome JS, Cotton CA, Perlman EJ, et al.: Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol 24 (15): 2352-8, 2006.
[PUBMED Abstract]
|
|
|
